| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |